JS Capital Management’s GeneDx Holdings WGS Stock Holding History

JS Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,303	Closed	-$878K	–	26
2022 Q3	$878K	Hold	30,303	–	–	0.21%	19
2022 Q2	$1.26M	Hold	30,303	–	–	0.21%	16
2022 Q1	$3.07M	Hold	30,303	–	–	0.24%	23
2021 Q4	$4.46M	Hold	30,303	–	–	0.2%	34
2021 Q3	$7.59M	Buy	+30,303	New	+$10.4M	0.44%	33

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JS Capital Management's WGS Position: Q4 2022 in Review

JS Capital Management sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 30,303 shares — an estimated $878K sold.

JS Capital Management first reported a position in WGS in Q3 2021 and held it in 5 quarters. The position peaked at $7.59M in Q3 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

JS Capital Management reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
JS Capital Management sold 30,303 GeneDx Holdings shares in Q4 2022, an estimated $878K.
JS Capital Management first reported a position in GeneDx Holdings in Q3 2021 and held it in 5 quarters.
JS Capital Management's GeneDx Holdings position peaked at $7.59M in Q3 2021.
86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on JS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.